The award contains prize cash of $350,000 and entry to Johnson & Johnson Medical Gadget Corporations’ lab house for a yr residency, will assist get its product to market, stated Anna Lisa Somera, chief government officer of Rhaeos.
Hydrocephalus is primarily handled with a shunt, which is a small tube and a related valve. Nevertheless, these gadgets commonly fail, generally with life-threatening penalties, and require monitoring with X-Rays or CT scans that may typically expose sufferers to vital quantities of radiation.
The illness impacts about a million Individuals and the identical remedy has used for many years.
Rhaeos’ FlowSense makes use of thermal measuring on a wi-fi machine hooked up to the pores and skin close to the collar bone to monitor ventricular shunt perform in sufferers.
“We’re making an attempt to take the guesswork out of this,” she stated. “The screens would present one other weapon for clinicians past imaging.”
The FlowSense wearable shunt monitor has been in medical trials at Northwestern Memorial Hospital and Ann & Robert H. Lurie Kids’s Hospital. In June, it obtained breakthrough machine designation from the U.S. Meals and Drug Administration, which can assist the corporate work with the federal company to streamline the clearance course of.
The MedTech award will give the expertise better trade recognition, stated Northwestern inventor John Rogers, whose group beforehand debuted a versatile patch worn on the pores and skin that screens stroke sufferers and is engaged on one other to detect and monitor COVID-19.
“We’ve taken a lean startup method with Rhaeos, with no dilutive capital,” stated Rogers, including that the prize cash additionally strikes “the ball when it comes to expertise and regulatory approval.”
Bringing shunt monitoring to market may very well be solely the start for the easy fluid sensing expertise.
“The machine is extra typically centered on measuring flows in a non-invasive method,” which might embrace quite a few medical purposes, Rogers stated, including that Rhaeos’ CEO Somera “is placing collectively a broader story that this can be a platform expertise.”
Somera got here to Rhaeos after consulting on different tasks for his group as a outstanding determine within the Chicago medical tech neighborhood. Somera began as chief working officer in June of 2019 and have become CEO in January 2020. She beforehand labored on the administration groups of startup corporations together with OrthoAccel Applied sciences, Diagnostic Photonics, Innoblative Designs, and Briteseed.